Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Quantitative MRI for Analysis of Active Multiple Sclerosis Lesions without Gadolinium-Based Contrast Agent.
Internal jugular vein entrapment in a multiple sclerosis patient.
Non-Significant Associations Between Measures of Inhibitory Control and Walking While Thinking in Persons with Multiple Sclerosis.
[Non-medicinal treatments of spasticity in multiple sclerosis].
[Ginkgolide B promotes axonal growth of retina ganglion cells by anti-apoptosis in vitro].
Natural killer cells in human autoimmune disorders.
Is There Extra Cost of Institutional Care for MS Patients?
AAV1.NT-3 gene therapy for Charcot-Marie-Tooth neuropathy.
Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the US.
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.
Fatigue is associated with poor sleep in people with multiple sclerosis and cognitive impairment.
Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS.
HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells.
The etiology of ring lesions on diffusion-weighted imaging.
Pharyngeal electrical stimulation for dysphagia associated with multiple sclerosis: A pilot study.
Triptolide with Potential Medicinal Value for Diseases of the Central Nervous System.
Vitamin D and multiple sclerosis.
Consensus Recommendations for the Diagnosis and Treatment of Multiple Sclerosis The Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis (MENACTRIMS).
Human antigen R binding and regulation of SOX2 mRNA in human mesenchymal stem cells.
Falls and physical activity in persons with multiple sclerosis.
Multiple sclerosis: Characterization of lesion evolution in relapsing-remitting and secondary progressive multiple sclerosis.
Extended-release dalfampridine in the management of multiple-sclerosis-related walking impairment.
Low serum urate levels are associated to female gender in multiple sclerosis patients.
Severe multiple sclerosis reactivation under fingolimod 3 months after natalizumab withdrawal.
A Randomized Trial Evaluating Various Administration Routes of Natalizumab in Multiple Sclerosis.

Pages